ADXN
Addex Therapeutics Ltd
NASDAQ · Healthcare · Biotechnology · CH
$3.65
−1.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.57x
- Price / sales
- 69.77x
- Price / cash flow
- -2.22x
Enterprise value
- Enterprise value
- $5.4M
- EV / sales
- 58.49x
- EV / EBITDA
- -0.61x
- EV / EBIT
- -1.61x
- Market cap
- $6.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026